-+ 0.00%
-+ 0.00%
-+ 0.00%

LANTERN PHARMA - OVER 70% OF L858R PATIENTS SHOW TUMOR REDUCTION; 77% CLINICAL BENEFIT RATE

Reuters·06/02/2026 12:13:00

Please log in to view news